Pi-Cardia developed a unique non-implant catheter based treatment for patients with heart valve calcification, addressing a multi-billion dollar market
Pi-Cardia developed a unique non-implant based mechanical catheter for fracturing valve calcification, which is a multi-billion dollar, most rapidly growing market in cardiology today. We have completed our product development and gained approvals for clinical studies in EU. We are raising $3-6M for performing the studies, and believe that upon demonstrating clinical safety and efficacy, Pi-Cardia will be in a unique position in the valve space